$TXTM operates two wholly owned subsidiaries; Plan
Post# of 74526
![Avatar](/images/ProfileImages/347566354_1498_zz.png)
Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Plandai Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Our initial product, Phytofare Catechin Complex, has been clinically shown to have 10 times greater bioavailability over generic catechin extracts.
Cannabis Biosciences is actively pursuing government licenses and permits that will allow it to use its proprietary processing and extraction technology to commence investigations and produce a full-profile cannabis extract, one that contains both CBD and the precursor acid form of THC (THC-A and THC-
![B) B)](smileys/cool.gif)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)